Effects of the Enzira® flu vaccine (13-501); version 1

• Research type

  Research Study

• Full title

  A Phase IV, Single-Centre, Open-label Study to Evaluate the Immunogenicity and Safety of the 2013/2014 Formulation of the Enzira® vaccine in Two Groups of Healthy Volunteers: ‘Adults’ (aged 18 to 59 years) and ‘Older Adults’ (aged 60 years or older). (HMR code:13-501)

• IRAS ID

  127534

• Contact name

  Gary Peters

• Contact email

  vparker@hmrlondon.com

• Sponsor organisation

  bioCSL Pty Ltd

• Eudract number

  2013-000945-37

• Clinicaltrials.gov Identifier

  NCT01857297

• REC name

  West of Scotland REC 1

• REC reference

  13/WS/0080

• Date of REC Opinion

  2 May 2013

• REC opinion

  Further Information Favourable Opinion